An Adult Case of Beta Thalassemia with Right Ventricular Outflow Tract Tachycardia: A Case Report
Article Sidebar
Main Article Content
Abstract
Beta thalassemia major is a genetic disorder requiring recurrent blood transfusion leading to iron overload in endocrine glands and major organs like the heart. Iron overload in the heart may lead to many conduction abnormalities. This is a case report of a 20-year-old female who was on recurrent blood transfusion. She was on chelation therapy for iron overload. She developed Right Ventricular Outflow Tract Tachycardia (RVOT) which could not be managed with chemical or electrical cardioversion. Her condition was successfully managed with an Automatic Implantable Cardioverter Defibrillator (AICD) implantation and no ventricular tachycardia was observed even after four years of follow-up.
Article Details
Copyright (c) 2024 Prem AS, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Cardiology and Cardiovascular Medicine is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Cardiology and Cardiovascular Medicine is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Rund D, Rachmilewitz E. β-Thalassemia. New England Journal of Medicine. 2005;353:1135-1146. Available from: https://doi.org/10.1056/nejmra050436
Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021;9(12):e1788. Available from: https://doi.org/10.1002/mgg3.1788
Lei M qing, Sun L Feng, Luo X Sheng, Yang X Yang, Yu F, Chen X Xia, et al. Distinguishing iron deficiency anemia from thalassemia by the red blood cell lifespan with a simple CO breath test: a pilot study. J Breath Res. 2019;13(2):026007. Available from: https://doi.org/10.1088/1752-7163/aafe4f
Borgna-Pignatti C, Galanello R. Thalassemias and related disorders: quantitative disorders of hemoglobin synthesisatology. In: Wintrobe’s Clinical Hematology. 11th ed. Philadelphia: Lippincott Williams & Wilkins. 2004.
Pippard MJ, Warner GT, Callender ST, Weatherall DJ. Iron Absorption And Loading In Β-Thalassæmia Intermedia. The Lancet. 1979;314(8147):819-821. Available from: https://doi.org/10.1016/s0140-6736(79)92175-5
Weatherall DavidJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331-4336. Available from: https://doi.org/10.1182/blood-2010-01-251348
Wood JC. Cardiac Complications in Thalassemia Major. Hemoglobin. 2009;33(sup1):S81–6. Available from:https://doi.org/10.3109/03630260903347526
Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood. 2005;105(10):4103-4105. Available from: https://doi.org/10.1182/blood-2004-12-4844
Wongjaikam S, Kumfu S, Chattipakorn SC, Fucharoen S, Chattipakorn N. Current and future treatment strategies for iron overload cardiomyopathy. Eur J Pharmacol. 2015;765:86-93. Available from: https://doi.org/10.1016/j.ejphar.2015.08.017
Auger D, Pennell DJ. Cardiac complications in thalassemia major: Iron and the heart. Ann N Y Acad Sci. 2016;1368(1):56-64. Available from: https://doi.org/10.1111/nyas.13026
Ramazzotti A, Pepe A, Positano V, Scattini B, Santarelli MF, Landini L, et al. Standardized T2* Map of a Normal Human Heart to Correct T2* Segmental Artefacts; Myocardial Iron Overload and Fibrosis in Thalassemia Intermedia Versus Thalassemia Major Patients and Electrocardiogram Changes in Thalassemia Major Patients. Hemoglobin. 2008;32(1–2):97–107. Available from: https://doi.org/10.1080/03630260701879514
Bayar N, Arslan Ş, Erkal Z, Küçükseymen S. Sustained Ventricular Tachycardia in a Patient with Thalassemia Major: Sustained Ventricular Tachycardia. Ann Noninvasive Electrocardiol. 2014;19(2):193-197. Available from: https://doi.org/10.1111/anec.12085